Considering the relevance of GALR2-mediated pathophysiology, such as anxiety-like behavior22, and the putative role of SPX in appetite regulation9, a GALR2-specific agonist may prove useful for the treatment of obesity and anxiety disorders. This evidence concerns the gene GALR2 and Obesity.